1 asset in Ovarian Small Cell Carcinoma
Therapeutic assets addressing Ovarian Small Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Pembrolizumab Ovarian Small Cell Carcinoma | ARCAGY/ GINECO GROUP | P2 | CCC (53) |